Duncan Howie

Associate Director, Immunology at Enara Bio

Duncan joined Enara Bio in 2019 to lead the cellular and molecular immunology research efforts for the company, after an extensive academic research career.

Prior to joining Enara Bio, Duncan held a research position at The Sir William Dunn School of Pathology at Oxford University and jointly held a lectureship in Pathology at Wadham College, where he was responsible for teaching undergraduate Medicine. Duncan brings a wealth of research expertise and knowledge of inflammation, T-cell biology and molecular immunology to his role at Enara Bio, having authored over 60 publications in the field. Duncan has also acted as a reviewer for multiple top-tier immunology journals, funding agencies and serves as an associated editor for Frontiers in Immunology.

Duncan holds a BSc (1st class) in Experimental Pathology from the University of Glasgow, graduated with a PhD in Immunology from the University of London, and completed a post-doctoral fellowship at Harvard Medical School.

Location

Oxford, United Kingdom

Links


Org chart

No direct reports

Teams


Offices

This person is not in any offices


Enara Bio

Enara Bio’s mission is to shine a light on unconventional targets and develop the next generation of cancer immunotherapies designed to treat a broad patient population. Enara Bio is exploring the hidden depths of cancer and T-cell biology to discover and characterize novel immunotherapy targets, such as MR1-presented ligands and Dark Antigens™, which arise from altered cellular processes in cancer cells.


Industries

Employees

11-50

Links